COMMUNIQUÉS West-GlobeNewswire

Immunovant Reports Financial Results and Provides Corporate Updates for the Quarter Ended June 30, 2024
06/08/2024
Completed enrollment in batoclimab pivotal Myasthenia Gravis (MG) trial; top-line results and initiation of a potentially registrational program for IMVT-1402 on track for fiscal year end (March 31, 2025) Progressed [...]
PetMeds® Announces Fiscal 2025 First Quarter Financial Results
06/08/2024
Net Income for first quarter fiscal 2025 was $3.8 million or $0.18 diluted earnings per share DELRAY BEACH, Fla., Aug. 06, 2024 (GLOBE NEWSWIRE) -- PetMed Express, Inc. dba PetMeds and parent company of PetCareRx ( [...]
Cytek Biosciences Reports Second Quarter 2024 Financial Results
06/08/2024
FREMONT, Calif., Aug. 06, 2024 (GLOBE NEWSWIRE) -- Cytek ® Biosciences, Inc. (“Cytek Biosciences” or “Cytek”) (Nasdaq: CTKB), a leading cell analysis solutions company, today reported financial results for the second [...]
Pennant Reports Second Quarter 2024 Results
06/08/2024
Conference Call and Webcast scheduled for tomorrow, August 7, 2024 at 10:00 am MT EAGLE, Idaho, Aug. 06, 2024 (GLOBE NEWSWIRE) -- The Pennant Group, Inc. (NASDAQ: PNTG), the parent company of the Pennant group of [...]
Myriad Genetics Reports Strong Second Quarter 2024 Financial Results, including 15% Revenue Growth Year-Over-Year; Raises 2024 Financial Guidance and Long-Term Revenue Growth Target to 12%
06/08/2024
Highlights Second quarter revenue grew 15% year-over-year to $212 million , driven by Prenatal ( 25% ), Pharmacogenomics ( 22% ), and Hereditary Cancer ( 19% ). Second quarter GAAP earnings per share improved to $(0.41 [...]
Cognos Therapeutics Announces Formation of Industry Advisory Board
06/08/2024
Mark Webster Appointed Co-Chair of Advisory Board INGLEWOOD, CA, Aug. 06, 2024 (GLOBE NEWSWIRE) -- Cognos Therapeutics (“Cognos” and “the Company”), a leading innovator in medical technology, today proudly announced the [...]
Pliant Therapeutics to Participate in the Canaccord Genuity 44th Annual Growth Conference
06/08/2024
SOUTH SAN FRANCISCO, Calif., Aug. 06, 2024 (GLOBE NEWSWIRE) -- Pliant Therapeutics, Inc. (Nasdaq: PLRX) today announced that Keith Cummings, M.D., Chief Financial Officer, and Éric Lefebvre, M.D., Chief Medical Officer [...]
Progyny, Inc. Announces Second Quarter 2024 Results
06/08/2024
Achieves Record Quarterly Adjusted EBITDA, Strong Cash Flow Conversion Rate Board Authorizes Repurchase of $100 Million of Common Stock NEW YORK, Aug. 06, 2024 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY) (“Progyny [...]
Inspire Medical Systems, Inc. Board Authorizes Share Repurchase Program
06/08/2024
MINNEAPOLIS, Aug. 06, 2024 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) (Inspire, or the company), a medical technology company focused on the development and commercialization of innovative, minimally [...]
Neuronetics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
05/08/2024
MALVERN, Pa., Aug. 05, 2024 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a commercial stage medical technology company focused on designing, developing, and marketing products that improve the quality of life [...]
Vision Sensing Acquisition Corp. Announces Payment of Fee to Extend Period to Consummate Initial Business Combination to September 3, 2024
05/08/2024
New York, Aug. 05, 2024 (GLOBE NEWSWIRE) -- Vision Sensing Acquisition Corp. (NASDAQ: VSACU, VSAC, VSACW) (the “ Company ”) a special purpose acquisition company, announced today that on August 2, 2024, its sponsor, [...]
Information mensuelle relative au nombre total des droits de vote et d’actions composant le capital social
05/08/2024
(Article 223-16 du Règlement Général de l’Autorité des Marchés Financiers) PARIS, 05 août 2024 (GLOBE NEWSWIRE) -- Place de cotation : Euronext Growth ISIN code: FR0010425595 Date Nombre total d’actions composant le [...]
Monthly information on share capital and company voting rights
05/08/2024
(Article 223-16 of General Regulation of the French financial markets authority) PARIS, Aug. 05, 2024 (GLOBE NEWSWIRE) -- Listing market: Euronext Growth ISIN code: FR0010425595 Date Total number of shares in the [...]
ORIC Pharmaceuticals Expands Leadership Team with the Appointment of Keith Lui as Senior Vice President of Commercial and Medical Affairs
05/08/2024
SOUTH SAN FRANCISCO, Calif. and SAN DIEGO, Aug. 05, 2024 (GLOBE NEWSWIRE) -- ORIC Pharmaceuticals, Inc. (Nasdaq: ORIC), a clinical stage oncology company focused on developing treatments that address mechanisms of [...]
Anaptys Announces Second Quarter 2024 Financial Results and Provides Business Update
05/08/2024
Top-line data expected in December 2024 after having completed enrollment for Phase 2b trial to treat atopic dermatitis (AD) with ANB032, our BTLA agonist Top-line data accelerated and now anticipated in Q1 2025 for [...]
OrthoPediatrics Corp. Reports Second Quarter 2024 Financial Results and Reaffirms Full Year 2024 Revenue Guidance
05/08/2024
Record Second Quarter 2024 Revenue Increased 33% Year-over-Year WARSAW, Ind., Aug. 05, 2024 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics” or the “Company”) (Nasdaq: KIDS), a company focused exclusively on [...]
OrthoPediatrics Corp. Announces Private Financing
05/08/2024
Term Loan and Private Placement of Convertible Notes Will Provide Up To $100 Million of Capital WARSAW, Ind., Aug. 05, 2024 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics”) (NASDAQ: KIDS), a company focused [...]
SI-BONE, Inc. Reports Financial Results for the Second Quarter 2024
05/08/2024
Increases 2024 revenue guidance to $165 million - $167 million Expects to achieve positive Adjusted EBITDA in Fourth Quarter 2024 SANTA CLARA, Calif., Aug. 05, 2024 (GLOBE NEWSWIRE) -- SI-BONE, Inc. (Nasdaq:SIBN), a [...]
PetMed Express, Inc. Announces Appointment of Doug Krulik as Chief Accounting Officer
05/08/2024
Krulik Brings More than 20 Years of Leadership Experience in Finance and Accounting DELRAY BEACH, Fla., Aug. 05, 2024 (GLOBE NEWSWIRE) -- PetMed Express, Inc. , dba PetMeds and parent company of PetCareRx , (Nasdaq: [...]

Pages